Results 281 to 290 of about 249,781 (322)
Some of the next articles are maybe not open access.
Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation.
New England Journal of Medicine, 2023BACKGROUND Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy alone, in patients with heart failure are now ...
G. Stone+16 more
semanticscholar +1 more source
Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation.
Journal of the American Medical Association (JAMA), 2023Importance There are limited data on the outcomes of transcatheter edge-to-edge mitral valve repair for degenerative mitral regurgitation (MR) in a real-world setting.
R. Makkar+15 more
semanticscholar +1 more source
European Journal of Heart Failure, 2023
Mitral regurgitation (MR) and tricuspid regurgitation (TR) are common in patients with heart failure (HF). The aim of this study was to investigate prevalence, clinical characteristics and outcomes of patients with or without isolated or combined MR and ...
M. Adamo+22 more
semanticscholar +1 more source
Mitral regurgitation (MR) and tricuspid regurgitation (TR) are common in patients with heart failure (HF). The aim of this study was to investigate prevalence, clinical characteristics and outcomes of patients with or without isolated or combined MR and ...
M. Adamo+22 more
semanticscholar +1 more source
Catheterization and cardiovascular interventions, 2021
To assess outcomes in patients with acute mitral regurgitation (MR) following acute myocardial infarction (AMI) who received percutaneous mitral valve repair (PMVR) with the MitraClip device and to compare outcomes of patients who developed cardiogenic ...
R. Estévez-Loureiro+30 more
semanticscholar +1 more source
To assess outcomes in patients with acute mitral regurgitation (MR) following acute myocardial infarction (AMI) who received percutaneous mitral valve repair (PMVR) with the MitraClip device and to compare outcomes of patients who developed cardiogenic ...
R. Estévez-Loureiro+30 more
semanticscholar +1 more source
The Lancet, 2009
Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of coronary disease) in developed countries, or rheumatic (in developing countries).
Maurice, Enriquez-Sarano+2 more
openaire +4 more sources
Mitral regurgitation affects more than 2 million people in the USA. The main causes are classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of coronary disease) in developed countries, or rheumatic (in developing countries).
Maurice, Enriquez-Sarano+2 more
openaire +4 more sources
JAMA cardiology, 2020
Importance Traditionally, physicians distinguished between mitral regurgitation (MR) as a determinant of outcomes and MR as a biomarker of left-ventricular (LV) dysfunction by designating the lesions as primary or secondary, respectively.
M. Packer, P. Grayburn
semanticscholar +1 more source
Importance Traditionally, physicians distinguished between mitral regurgitation (MR) as a determinant of outcomes and MR as a biomarker of left-ventricular (LV) dysfunction by designating the lesions as primary or secondary, respectively.
M. Packer, P. Grayburn
semanticscholar +1 more source
Current Treatment Options in Cardiovascular Medicine, 2000
Chronic severe mitral regurgitation is a surgically correctable disorder. Advances in cardiac surgery (including mitral valve repair and less invasive operations), a low postoperative complication rate, and improved long-term prognosis have reduced the threshold for surgical referral. Choosing the optimal timing for surgery remains the cardinal problem.
William J. Stewart, Craig R. Asher
openaire +3 more sources
Chronic severe mitral regurgitation is a surgically correctable disorder. Advances in cardiac surgery (including mitral valve repair and less invasive operations), a low postoperative complication rate, and improved long-term prognosis have reduced the threshold for surgical referral. Choosing the optimal timing for surgery remains the cardinal problem.
William J. Stewart, Craig R. Asher
openaire +3 more sources
Degenerative mitral regurgitation
Current Opinion in Cardiology, 2020Purpose of review Degenerative mitral regurgitation (DMR) continues to be an important cause of morbidity and mortality with surgical mitral valve repair remaining the gold standard for the treatment of severe disease. The purpose of this review is to summarize recent advances in the understanding of DMR as well as the progress
Soulat-Dufour, Laurie, Addetia, Karima
openaire +4 more sources
JAMA cardiology, 2020
Importance Two randomized clinical trials of transcatheter edge-to-edge mitral valve repair in patients with secondary mitral regurgitation (the Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe ...
W. Gaasch, G. Aurigemma, T. Meyer
semanticscholar +1 more source
Importance Two randomized clinical trials of transcatheter edge-to-edge mitral valve repair in patients with secondary mitral regurgitation (the Multicentre Randomized Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients With Severe ...
W. Gaasch, G. Aurigemma, T. Meyer
semanticscholar +1 more source
Echocardiography, 2020
Mitral annular disjunction is a structural abnormality of the mitral annulus fibrosus which is often associated with mitral leaflet prolapse. However, few reports have described mitral annular disjunction in mitral valve prolapse (MVP).
T. Konda+7 more
semanticscholar +1 more source
Mitral annular disjunction is a structural abnormality of the mitral annulus fibrosus which is often associated with mitral leaflet prolapse. However, few reports have described mitral annular disjunction in mitral valve prolapse (MVP).
T. Konda+7 more
semanticscholar +1 more source